Alpha RegistryClaim a profile
Published mark

GRI Bio, Inc.

NASDAQ: GRI. Canonical company identity and public leadership record.

US

Record source reportedRecord not claimedNo Eval published
Follow companySave PDF
Alpha ID
alpha:company:8c8240a3-2d69-4476-9790-eca3ef6ba0ff
SEC CIK
0001824293
Record version
vpublic-1:ro-d751713988987e9331980363e24189ce, published Oct 18, 2026
Newest evidence
Jan 30, 2026
Monitoring
Not yet monitored Details
Integrity
Not yet signed Methodology
CEO
W. Marc Hertz, Ph.D.Since Jan 30, 2026
Chair
David Szekeres
Independent
Not published7 directors published
Published claims
203 distinct sources
Evidence records
60 pinned
Source conflicts
0None open

Built from 3 distinct sources and 6 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.

CorroboratedSource reportedAlpha inferenceNot disclosed

Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works

EXECUTIVE APPOINTED

Albert Agro, Ph.D. executive of GRI Bio, Inc., effective 2026-01-30.

EffectiveEffective Jan 30, 2026E4

Monitoring

Continuous

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

  • Identityunclaimed
    Published
  • Evidencesource_reported
    Published
  • Evaluationnot_evaluated
    Published
  • MonitoringNot yet published for this record.
    Not published
  • AuthorityNot yet published for this record.
    Not published
  • Freshnesscurrent
    Published

Leadership

Evidence
RolePersonSinceStatusClaim
Chief Medical OfficerAlbert Agro, Ph.D.Jan 2026currentSource reportedE4
Chief Scientific OfficerVipin Kumar, Ph.D.Jan 2026currentSource reportedE5
President, Chief Executive Officer and DirectorW. Marc Hertz, Ph.D.Jan 2026currentSource reportedE6
Chief Medical OfficerAlbert AgroNot capturedunknownSource reportedE2
Chief Financial OfficerLeanne KellyNot capturedunknownSource reportedE2
Chief Scientific OfficerVipin Kumar ChaturvediNot capturedunknownSource reportedE2
President and Chief Executive OfficerW. Marc HertzNot capturedunknownSource reportedE2

Board of directors

Evidence

7 directors published. Independence determinations are not published for every director.

DirectorStatusSinceCommitteesClaim
Albert Agro, Ph.D.Independence not published2025None publishedSource reportedE3
Camilla V. SimpsonIndependence not published2023None publishedSource reportedE3
David BakerIndependence not published2019None publishedSource reportedE3
Leanne KellyIndependence not published2025None publishedSource reportedE3
Roelof RongenIndependence not published2023None publishedSource reportedE3
Vipin Kumar ChaturvediIndependence not published2025None publishedSource reportedE3
W. Marc Hertz, Ph.D.Independence not published2025None publishedSource reportedE3
David SzekeresIndependentChairNot publishedNone publishedSource reportedE2
W. Marc HertzNot independentNot publishedChief Executive Officer and DirectorSource reportedE2

Committees and risk ownership

Evidence
CommitteeChairMembersRisks assigned
Chief Executive Officer and DirectorNot publishedW. Marc HertzNot described in the published record

Control and voting power

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Authority to act

Evidence and agent registry

Who can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.

Principal executive officerW. Marc Hertz, Ph.D., President, Chief Executive Officer and Director, from Jan 30, 2026
Source reportedE6
company:8c8240a3-2d69-4476-9790-eca3ef6ba0ff:leadership_role:20
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
bind
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
agents
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
delegations

Financials and market context

Evidence
Security ListingGRI (NASDAQ)
Source reportedE1
company:8c8240a3-2d69-4476-9790-eca3ef6ba0ff:security_listing:21
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 18, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.

Governance and policies

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Risk, audit, and cyber

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

AI oversight and accountability

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Compensation

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Other published claims

Evidence

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

Legal NameGRI Bio, Inc.
Source reportedE1
company:8c8240a3-2d69-4476-9790-eca3ef6ba0ff:legal_name:1
Entity StatusPublic listing published
Source reportedE1
company:8c8240a3-2d69-4476-9790-eca3ef6ba0ff:entity_status:3

Not yet in this record

Coverage

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

  • Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
  • OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
  • FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
  • CompensationNot reviewed. Pay design shows how incentives are governed.
  • GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
  • Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
  • AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
  • LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
  • RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
  • CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
  • AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
  • Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.

Subject and corrections

Public-role doctrine

This record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.

Basis
Published company record built from public sources
Sources
6 evidence records cited. 0 with redistribution rights.
Never published
Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
Record claimed
No
Open disputes
0
Identity ownership
unclaimed
Claiming not yet available

If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.

Evidence

Authority and rights
  1. E1
    Alpha canonical company public projection
    Alpha canonical company public projection. canonical identity. Retrieved Oct 18, 2026. Cited by 4 Claims.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  2. E2
    SEC DEF 14A 0001824293-25-000089
    sec def 14a. Published Jul 11, 2025. Retrieved Sep 6, 2026. Cited by 6 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  3. E3
    DEF 14A a2025proxystatement.htm
    sec proxy. Published Jul 11, 2025. Retrieved Sep 2, 2026. Cited by 7 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  4. E4
    GRI 10-K executive officers
    sec filing. Published Jan 30, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  5. E5
    GRI 10-K executive officers
    sec filing. Published Jan 30, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  6. E6
    GRI 10-K executive officers
    sec filing. Published Jan 30, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned

What changed in version public-1:ro-d751713988987e9331980363e24189ce

vpublic-1:ro-d751713988987e9331980363e24189ce published Oct 18, 2026
  • Albert Agro, Ph.D. executive of GRI Bio, Inc., effective 2026-01-30.
  • Vipin Kumar, Ph.D. executive of GRI Bio, Inc., effective 2026-01-30.
  • W. Marc Hertz, Ph.D. executive of GRI Bio, Inc., effective 2026-01-30.
  • Albert Agro, Ph.D. seat on GRI Bio, Inc., effective 2025-07-11.
  • Leanne Kelly seat on GRI Bio, Inc., effective 2025-07-11.
  • Vipin Kumar Chaturvedi seat on GRI Bio, Inc., effective 2025-07-11.
  • W. Marc Hertz, Ph.D. seat on GRI Bio, Inc., effective 2025-07-11.
  • Camilla V. Simpson seat on GRI Bio, Inc., effective 2023-01-01.
  • Roelof Rongen seat on GRI Bio, Inc., effective 2023-01-01.
  • David Baker seat on GRI Bio, Inc., effective 2019-01-01.
Appearance

Alpha Governance PBC. The Registry records reported facts and Alpha's assessments separately. A missing fact is not evidence that it is false.

Record alpha:company:8c8240a3-2d69-4476-9790-eca3ef6ba0ff, version public-1:ro-d751713988987e9331980363e24189ce. https://registry.alpha.ac/companies/gri-bio-inc

Navigate

On this record

  1. Overview
  2. Monitoring4
  3. Leadership7
  4. Board9
  5. Committees1
  6. Control and voting0
  7. Authority to act4
  8. Financials1
  9. Governance0
  10. Risk0
  11. AI oversight0
  12. Legal0
  13. Compensation0
  14. Other published claims3
  15. Coverage gaps17
  16. Linked people11
  17. Subject and corrections6
  18. Evidence6
  19. Version historyvpublic-1:ro-d751713988987e9331980363e24189ce

Linked records

Registry

Appearance

esc
  • Actions
    Switch to agent viewJSON, Markdown, MCP
  • Copy Alpha IDalpha:company:8c8240a3-2d69-4476-9790-eca3ef6ba0ff
  • Cite this recordGRI Bio, Inc.
  • Copy canonical URLregistry.alpha.ac/companies/gri-bio-inc
  • Copy as MarkdownWith assertion states
  • Report an error
  • Theme: System
  • Theme: Light
  • Theme: Dark
  • Records
    GRI Bio, Inc.Company
  • Albert Agro, Ph.D.Person
  • Vipin Kumar, Ph.D.Person
  • W. Marc Hertz, Ph.D.Person
  • Albert AgroPerson
  • Leanne KellyPerson
  • Vipin Kumar ChaturvediPerson
  • W. Marc HertzPerson
  • Camilla V. SimpsonPerson
  • David BakerPerson
  • Roelof RongenPerson
  • David SzekeresPerson
  • Sections
    OverviewGRI Bio, Inc.
  • MonitoringGRI Bio, Inc.
  • LeadershipGRI Bio, Inc.
  • BoardGRI Bio, Inc.
  • CommitteesGRI Bio, Inc.
  • Control and votingGRI Bio, Inc.
  • Authority to actGRI Bio, Inc.
  • FinancialsGRI Bio, Inc.
  • GovernanceGRI Bio, Inc.
  • RiskGRI Bio, Inc.
  • AI oversightGRI Bio, Inc.
  • LegalGRI Bio, Inc.
  • CompensationGRI Bio, Inc.
  • Other published claimsGRI Bio, Inc.
  • Coverage gapsGRI Bio, Inc.
  • Linked peopleGRI Bio, Inc.
  • Subject and correctionsGRI Bio, Inc.
  • EvidenceGRI Bio, Inc.
  • Version historyGRI Bio, Inc.
↑ ↓ move↵ openThis record only

Report an error

Reports attach to the Claim and go to an Alpha analyst through the correction form. Corrections are versioned, and the original stays in history.